Sanofi India Limited has reported standalone financial results for the period ended March 31, 2024.

Sanofi India has posted net profit of Rs. 136.6 crores for the period ended March 31, 2024 as against net profit of Rs. 137.7 crores for the period ended December 31, 2023. The company posted net profit of Rs.190.4 crores for the period ended March 31, 2023.

Sanofi India has reported total income of Rs. 738.9 crores during the period ended March 31, 2024 as compared to Rs. 705.9 crores during the period ended December 31, 2023. The company reported total income of Rs.762.3 crores during the period ended March 31, 2023.

During the quarter ended March 31, 2024, the Company has entered into a promotion and distribution agreement with Emcure Pharmaceuticals Limited for its cardiovascular and hospital business products and also entered into a promotion and distribution agreement with Cipla Limited for its central nervous system business products.